Selected article for: "fusion protein and protein expression"

Author: Lennemann, Nicholas J.; Rhein, Bethany A.; Ndungo, Esther; Chandran, Kartik; Qiu, Xiangguo; Maury, Wendy
Title: Comprehensive Functional Analysis of N-Linked Glycans on Ebola Virus GP1
  • Document date: 2014_1_28
  • ID: 6sb3ipab_2
    Snippet: Several roles have been attributed to glycans attached to viral glycoproteins. Glycans can serve as ligands for Ca 2Ï© -dependent (C-type) lectins (CLECs), facilitating viral attachment and internalization in a variety of cell types (10) . Additionally, glycans promote protein folding/stability and virion incorporation of GP, as demonstrated in studies with Newcastle disease virus and Lassa virus (11, 12) . In the case of Nipah virus G/F proteins.....
    Document: Several roles have been attributed to glycans attached to viral glycoproteins. Glycans can serve as ligands for Ca 2Ï© -dependent (C-type) lectins (CLECs), facilitating viral attachment and internalization in a variety of cell types (10) . Additionally, glycans promote protein folding/stability and virion incorporation of GP, as demonstrated in studies with Newcastle disease virus and Lassa virus (11, 12) . In the case of Nipah virus G/F proteins, not only does glycosylation help protein expression, it also decreases membrane fusion efficiency, thereby controlling premature fusion events (13, 14) . Furthermore, the glycans on human immunodeficiency virus (HIV) gp120/gp41, Nipah virus G/F, hepatitis C virus E1/E2, and influenza A virus hemagglutinin (HA) protect virions from antibody-mediated neutralization (15) . Despite the high degree of glycosylation found on filovirus GPs, the importance of the N-linked glycans on EBOV GP1 to the structure and function of the protein has not been well studied. Here, we assess the structural and functional importance of N-linked glycans on EBOV GP1.

    Search related documents:
    Co phrase search for related documents
    • cell type and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell type and protein function structure: 1, 2, 3
    • cell type variety and protein expression: 1, 2
    • disease virus and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease virus and protein function structure: 1, 2, 3, 4
    • fold stability and protein function structure: 1
    • function structure and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • function structure and protein function structure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • fusion efficiency and protein expression: 1
    • high degree and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • high degree and protein function structure: 1
    • human immunodeficiency and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • human immunodeficiency and protein function structure: 1, 2
    • human immunodeficiency virus and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • human immunodeficiency virus and protein function structure: 1, 2
    • internalization viral attachment and protein expression: 1
    • Lassa virus and protein expression: 1, 2
    • Newcastle disease virus and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15